IMRIS Inc.
IMRSQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$626
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $626.00 |
|---|---|
| Enterprise Value | $35.34 Million |
| Earnings per Share | $-0.58 |
| Beta | 7.79 |
| Outstanding Shares | 52,834,701 |
Return
| Return on Equity | -257.74% |
|---|---|
| Return on Assets | -46.40% |
| Return on Invested Capital | -75.73% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.22 |
| Enterprise Value to EBIT | -1.38 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.14 |
| Debt to Equity | 3.42 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About IMRIS Inc.
121 employees
CEO: Marc Buntaine
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and ...